Pfizer, Genmab
US FDA grants full approval for Pfizer's cervical cancer drug
The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on Monday.
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Pfizer cervical cancer drug gets full approval
The FDA has granted full approval for Pfizer's Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.
FDA Grants Full Approval for Pfizer’s Tivdak in Treating Advanced Cervical Cancer
In a significant development in the realm of oncology, the U.S. Food and Drug Administration (FDA) has bestowed full approval upon Pfizer’s groundbreaking drug, Tivdak, for the treatment of advanced cervical cancer.
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose
Pfizer's huge facility in North Carolina produces its first FDA-approved gene therapy, which runs $3.5 million a dose.
Pfizer, Genmab cervical cancer therapy wins full FDA approval
Pfizer (PFE) and Genmab (GMAB) announced Monday that the U.S. FDA accepted a sBLA granting full approval for their cervical cancer therapy, Tivdak.
Medscape1d
Cervical Cancer Screening: US Clinicians Unclear About Best Practices
In 2020, the American Cancer Society (ACS) updated its cervical screening guidelines, proposing two major changes: start ...
Cervical cancer vaccine roll-out shows efficacy in reducing cervical cancer and other HPV-related disease
With the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO ...
Indiatimes on MSN1d
Cervical cancer: Therapies that have transformed the treatment landscape
Cervical cancer treatment for Indian women involves various methods like surgery, radiation therapy, chemotherapy, and ...
Targeted Oncology11h
Slomovitz on Tisotumab Vedotin's Promise for Cervical Cancer
Brian Slomovitz, MD, details findings from the innovaTV 301 trial investigating tisotumab vedotin for the treatment of ...
Self7d
I Was Told I Had an STI. It Was Actually Cervical Cancer
Aisha McClellan, 39, from Chapel Hill, North Carolina, was diagnosed with metastatic cervical cancer when she was just 32.
Pharm Exec1d
FDA Grants Full Approval to Tivdak for Treating Recurrent or Metastatic Cervical Cancer Patients Experiencing Disease Progression After Chemotherapy
Approval of Tivdak was based on promising results from a Phase III innovaTV 301 clinical trial, which demonstrated a 30% ...
Monthly Prescribing Reference2d
Tivdak Gets Traditional Approval for Recurrent or Metastatic Cervical Cancer
The Food and Drug Administration (FDA) has granted full approval to Tivdak ® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or metastatic cervical cancer with disease ...
The SEC has Ethereum in its crosshairs. But does the agency think Ether is a security?
Consensys accused the SEC of secretly declaring Ether to be a security in an unredacted court filing on Monday, though the ...